避妊薬・避妊器具の世界市場レポート 2025年

避妊薬・避妊器具の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.5%で、363億1,000万米ドルに成長します。予測期間の成長は、長期作用型可逆的避妊薬への需要の高まり、女性のリプロダクティブヘルスへの関心の高まり、性感染症の有病率の上昇、eコマースやテレヘルスによるアクセスの拡大、ヘルスケア政策や保険適用への支援といった要因に起因すると考えられます。予測期間における主な動向としては、デジタル追跡機能を備えたスマート避妊具の開発、生分解性インプラントやパッチ、ホルモンフリー避妊具の革新、AIを活用した不妊治療モニタリングアプリ、カスタムフィット避妊具の3Dプリンティングなどが挙げられます。

リプロダクティブヘルスに焦点を当てた政府のイニシアチブの増加は、避妊薬・避妊器具市場の成長を促進すると予想されます。これらのイニシアチブは、啓発キャンペーン、資金提供、サービスへのアクセスを通じてリプロダクティブヘルスを促進することを目的としています。政府は、妊産婦の健康、家族計画、必要不可欠なヘルスケアサービスへのアクセスといった問題に取り組むことの重要性をますます認識するようになっており、これらはすべて社会の幸福と発展にとって極めて重要です。避妊薬・避妊器具を対象とした政府の取り組みは、手頃な価格で効果的な家族計画法へのアクセスを増やし、個人が生殖に関する健康について十分な情報を得た上で選択できるようにすることを目的としています。例えば、2024年11月、オーストラリア政府外務貿易省は、東南アジアにおける性と生殖に関する健康と権利の促進を目的とした新たなイニシアチブに5,680万米ドルを割り当てると発表しました。その結果、リプロダクティブヘルスに関連する政府のイニシアチブの増加が、避妊薬・避妊器具市場の成長を後押ししています。

避妊薬・避妊器具市場の主なプレーヤーは、避妊用膣リングなどの革新的な製品の開発に注力し、利便性を高め、長時間作用型の避妊法の選択肢を広げています。避妊用膣リングは、排卵を抑制して妊娠を防ぐために膣内に挿入する、柔軟性のあるホルモン放出デバイスです。例えば、2023年10月、米国の製薬会社Xiromed LLCは、エトノゲストレル（プロゲスチン）とエチニルエストラジオール（エストロゲン）の組み合わせを3週間かけて放出し、排卵を防ぐように設計されたソフトで柔軟な避妊用膣リング、EnilloRingを発売しました。NuvaRingと生物学的に同等なジェネリック医薬品であるEnilloRingは、先発品と同等の安全性、有効性、忍容性を維持しながら、毎日服用する必要がなく、目立たず、便利で、費用対効果の高い毎月の避妊オプションを女性に提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の避妊薬・避妊器具のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の避妊薬・避妊器具市場：成長率分析
• 世界の避妊薬・避妊器具市場の実績：規模と成長、2019～2024年
• 世界の避妊薬・避妊器具市場の予測：規模と成長、2024～2029年、2034年
• 世界の避妊薬・避妊器具総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の避妊薬・避妊器具市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 避妊薬
• 避妊器具
• 世界の避妊薬・避妊器具市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• 従来の避妊方法
• デジタル避妊アプリ
• ウェアラブルデバイス
• 長期作用型可逆的避妊薬（LARC）
• 世界の避妊薬・避妊器具市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• クリニック
• オンラインチャネル
• 公共チャネル・非政府組織
• その他
• 世界の避妊薬・避妊器具市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 男性
• 女性
• 世界の避妊薬・避妊器具市場：避妊薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口避妊薬
• 注射避妊薬
• 避妊パッチ
• 膣リング
• 緊急避妊薬
• ホルモンインプラント
• 世界の避妊薬・避妊器具市場：避妊器具のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 男性用コンドーム
• 女性用コンドーム
• 子宮内避妊器具（IUD）
• 子宮頸管キャップ・子宮内膜キャップ
• 避妊スポンジ
• 滅菌装置

第7章 地域別・国別分析

• 世界の避妊薬・避妊器具市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の避妊薬・避妊器具市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 避妊薬・避妊器具市場：競合情勢
• 避妊薬・避妊器具市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Teva Pharmaceuticals Ltd
• Lupin Limited
• CooperSurgical Inc.
• Mithra Pharmaceuticals
• DKT International
• Fuji Latex Co Ltd
• Agile Therapeutics Inc.
• Cupid Limited
• Veru Inc.
• Eskag Pharma Pvt. Ltd.
• Biosante Pharmaceuticals Inc.
• HLL Lifecare Limited
• Afaxys Inc.
• The Female Health Company（FC2）
• Mayer Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 避妊薬・避妊器具市場2029年：新たな機会を提供する国
• 避妊薬・避妊器具市場2029年：新たな機会を提供するセグメント
• 避妊薬・避妊器具市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Contraceptive drugs and devices are medical products designed to prevent pregnancy using various methods. Contraceptive drugs typically contain synthetic hormones that inhibit ovulation, thicken cervical mucus, or alter the uterine lining. On the other hand, contraceptive devices include physical barriers that block sperm from reaching the egg and systems inserted into the uterus to prevent fertilization or implantation.

The primary categories of contraceptive products are contraceptive drugs and contraceptive devices. Contraceptive drugs are medications that work by disrupting the normal processes of ovulation, fertilization, or implantation. The technologies involved range from traditional methods and digital contraceptive apps to wearable devices and long-acting reversible contraceptives (LARCs). These products are distributed through various channels such as hospital pharmacies, retail pharmacies, clinics, online platforms, public channels, and non-governmental organizations, serving a diverse range of end users, including both males and females.

The contraceptive drugs and devices market research report is one of a series of new reports from The Business Research Company that provides contraceptive drugs and devices market statistics, including contraceptive drugs and devices industry global market size, regional shares, competitors with a contraceptive drugs and devices market share, detailed contraceptive drugs and devices market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive drugs and devices industry. The contraceptive drugs and devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contraceptive drugs and devices market size has grown strongly in recent years. It will grow from$25.30 billion in 2024 to $27.24 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to factors such as population growth, heightened awareness of family planning, government initiatives and funding, a growing number of working women, and advancements in contraceptive technologies.

The contraceptive drugs and devices market size is expected to see strong growth in the next few years. It will grow to$36.31 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to factors such as the growing demand for long-acting reversible contraceptives, increasing focus on women's reproductive health, the rising prevalence of sexually transmitted infections, expanded access through e-commerce and telehealth, as well as supportive healthcare policies and insurance coverage. Major trends in the forecast period include the development of smart contraceptive devices with digital tracking, biodegradable implants and patches, innovations in hormone-free contraceptives, AI-driven fertility monitoring apps, and the 3D printing of custom-fit contraceptive devices.

The increasing number of government initiatives focused on reproductive health is expected to drive the growth of the contraceptive drugs and devices market. These initiatives aim to promote reproductive health through awareness campaigns, funding, and access to services. Governments are increasingly recognizing the importance of addressing issues such as maternal health, family planning, and access to essential healthcare services, all of which are crucial for societal well-being and development. Government efforts targeting contraceptive drugs and devices aim to increase access to affordable and effective family planning methods, enabling individuals to make informed choices about their reproductive health. For example, in November 2024, the Australian Government Department of Foreign Affairs and Trade announced an allocation of $56.8 million for a new initiative aimed at promoting sexual and reproductive health and rights in Southeast Asia. As a result, the rise in government initiatives related to reproductive health is boosting the growth of the contraceptive drugs and devices market.

Key players in the contraceptive drugs and devices market are focusing on developing innovative products, such as contraceptive vaginal rings, to enhance convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For example, in October 2023, Xiromed LLC, a U.S.-based pharmaceutical company, introduced EnilloRing, a soft, flexible contraceptive vaginal ring designed to release a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, EnilloRing provides women with a discreet, convenient, and cost-effective monthly birth control option that eliminates the need for daily dosing, while maintaining the same safety, efficacy, and tolerability as the branded version.

In March 2024, Insud Pharma SL, a Spain-based pharmaceutical company, acquired Viatris Inc.'s women's healthcare business for an undisclosed amount. This acquisition strengthens Insud Pharma's presence in emerging markets by acquiring two manufacturing facilities in India, enhancing its ability to supply oral contraceptives to global public health institutions. Viatris Inc., a U.S.-based pharmaceutical and healthcare company, specializes in oral and injectable contraceptives.

Major players in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., and Dare Bioscience Inc.

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in contraceptive drugs and devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the contraceptive drugs and devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contraceptive drugs and devices market consists of sales of hormonal pills, emergency contraceptives, contraceptive implants, intrauterine devices (IUDs), condoms, patches, and vaginal rings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptive Drugs And Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptive drugs and devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptive drugs and devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contraceptive drugs and devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Contraceptive Drugs; Contraceptive Devices
• 2) By Technology: Traditional Methods; Digital Contraceptive Apps; Wearable Devices; Long-Acting Reversible Contraceptives (LARCs)
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channels; Public Channels And Non-Governmental Organizations; Other Distribution Channels
• 4) By End User: Male; Female
• Subsegments:
• 1) By Contraceptive Drugs: Oral Contraceptive Pills; Injectable Contraceptives; Contraceptive Patches; Vaginal Rings; Emergency Contraceptive Pills; Hormonal Implants
• 2) By Contraceptive Devices: Male Condoms; Female Condoms; Intrauterine Devices (IUDs); Diaphragms And Cervical Caps; Contraceptive Sponges; Sterilization Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co Inc.; Bayer AG; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contraceptive Drugs And Devices Market Characteristics

3. Contraceptive Drugs And Devices Market Trends And Strategies

4. Contraceptive Drugs And Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Contraceptive Drugs And Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Contraceptive Drugs And Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Contraceptive Drugs And Devices Market Growth Rate Analysis
• 5.4. Global Contraceptive Drugs And Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Contraceptive Drugs And Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Contraceptive Drugs And Devices Total Addressable Market (TAM)

6. Contraceptive Drugs And Devices Market Segmentation

• 6.1. Global Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contraceptive Drugs
• Contraceptive Devices
• 6.2. Global Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Methods
• Digital Contraceptive Apps
• Wearable Devices
• Long-Acting Reversible Contraceptives (LARCs)
• 6.3. Global Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channels And Non-Governmental Organizations
• Other Distribution Channels
• 6.4. Global Contraceptive Drugs And Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.5. Global Contraceptive Drugs And Devices Market, Sub-Segmentation Of Contraceptive Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Contraceptive Pills
• Injectable Contraceptives
• Contraceptive Patches
• Vaginal Rings
• Emergency Contraceptive Pills
• Hormonal Implants
• 6.6. Global Contraceptive Drugs And Devices Market, Sub-Segmentation Of Contraceptive Devices, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male Condoms
• Female Condoms
• Intrauterine Devices (IUDs)
• Diaphragms And Cervical Caps
• Contraceptive Sponges
• Sterilization Devices

7. Contraceptive Drugs And Devices Market Regional And Country Analysis

• 7.1. Global Contraceptive Drugs And Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Contraceptive Drugs And Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptive Drugs And Devices Market

• 8.1. Asia-Pacific Contraceptive Drugs And Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptive Drugs And Devices Market

• 9.1. China Contraceptive Drugs And Devices Market Overview
• 9.2. China Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptive Drugs And Devices Market

• 10.1. India Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptive Drugs And Devices Market

• 11.1. Japan Contraceptive Drugs And Devices Market Overview
• 11.2. Japan Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptive Drugs And Devices Market

• 12.1. Australia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptive Drugs And Devices Market

• 13.1. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptive Drugs And Devices Market

• 14.1. South Korea Contraceptive Drugs And Devices Market Overview
• 14.2. South Korea Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptive Drugs And Devices Market

• 15.1. Western Europe Contraceptive Drugs And Devices Market Overview
• 15.2. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptive Drugs And Devices Market

• 16.1. UK Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptive Drugs And Devices Market

• 17.1. Germany Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptive Drugs And Devices Market

• 18.1. France Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptive Drugs And Devices Market

• 19.1. Italy Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptive Drugs And Devices Market

• 20.1. Spain Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptive Drugs And Devices Market

• 21.1. Eastern Europe Contraceptive Drugs And Devices Market Overview
• 21.2. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptive Drugs And Devices Market

• 22.1. Russia Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptive Drugs And Devices Market

• 23.1. North America Contraceptive Drugs And Devices Market Overview
• 23.2. North America Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptive Drugs And Devices Market

• 24.1. USA Contraceptive Drugs And Devices Market Overview
• 24.2. USA Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptive Drugs And Devices Market

• 25.1. Canada Contraceptive Drugs And Devices Market Overview
• 25.2. Canada Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptive Drugs And Devices Market

• 26.1. South America Contraceptive Drugs And Devices Market Overview
• 26.2. South America Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptive Drugs And Devices Market

• 27.1. Brazil Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptive Drugs And Devices Market

• 28.1. Middle East Contraceptive Drugs And Devices Market Overview
• 28.2. Middle East Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptive Drugs And Devices Market

• 29.1. Africa Contraceptive Drugs And Devices Market Overview
• 29.2. Africa Contraceptive Drugs And Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Contraceptive Drugs And Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Contraceptive Drugs And Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptive Drugs And Devices Market Competitive Landscape And Company Profiles

• 30.1. Contraceptive Drugs And Devices Market Competitive Landscape
• 30.2. Contraceptive Drugs And Devices Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptive Drugs And Devices Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceuticals Ltd
• 31.2. Lupin Limited
• 31.3. CooperSurgical Inc.
• 31.4. Mithra Pharmaceuticals
• 31.5. DKT International
• 31.6. Fuji Latex Co Ltd
• 31.7. Agile Therapeutics Inc.
• 31.8. Cupid Limited
• 31.9. Veru Inc.
• 31.10. Eskag Pharma Pvt. Ltd.
• 31.11. Biosante Pharmaceuticals Inc.
• 31.12. HLL Lifecare Limited
• 31.13. Afaxys Inc.
• 31.14. The Female Health Company (FC2)
• 31.15. Mayer Laboratories Inc.

32. Global Contraceptive Drugs And Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptive Drugs And Devices Market

34. Recent Developments In The Contraceptive Drugs And Devices Market

35. Contraceptive Drugs And Devices Market High Potential Countries, Segments and Strategies

• 35.1 Contraceptive Drugs And Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Contraceptive Drugs And Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Contraceptive Drugs And Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer